nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ALB—Auranofin—psoriatic arthritis	0.21	0.236	CbGbCtD
Vismodegib—ALB—Prednisone—psoriatic arthritis	0.0667	0.075	CbGbCtD
Vismodegib—ABCG2—Dexamethasone—psoriatic arthritis	0.0604	0.068	CbGbCtD
Vismodegib—ABCB1—Methylprednisolone—psoriatic arthritis	0.0576	0.0648	CbGbCtD
Vismodegib—ABCG2—Methotrexate—psoriatic arthritis	0.0485	0.0546	CbGbCtD
Vismodegib—CYP2C19—Prednisone—psoriatic arthritis	0.0432	0.0486	CbGbCtD
Vismodegib—ABCB1—Betamethasone—psoriatic arthritis	0.0374	0.0421	CbGbCtD
Vismodegib—ABCB1—Prednisolone—psoriatic arthritis	0.0369	0.0416	CbGbCtD
Vismodegib—ABCB1—Prednisone—psoriatic arthritis	0.0349	0.0392	CbGbCtD
Vismodegib—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0345	0.0388	CbGbCtD
Vismodegib—ALB—Methotrexate—psoriatic arthritis	0.0335	0.0376	CbGbCtD
Vismodegib—SHH—vertebral column—psoriatic arthritis	0.0328	0.578	CbGeAlD
Vismodegib—CYP2C8—Dexamethasone—psoriatic arthritis	0.0322	0.0362	CbGbCtD
Vismodegib—CYP2C19—Dexamethasone—psoriatic arthritis	0.027	0.0304	CbGbCtD
Vismodegib—CYP3A4—Triamcinolone—psoriatic arthritis	0.0261	0.0294	CbGbCtD
Vismodegib—CYP2C9—Dexamethasone—psoriatic arthritis	0.0224	0.0252	CbGbCtD
Vismodegib—CYP3A4—Betamethasone—psoriatic arthritis	0.0224	0.0252	CbGbCtD
Vismodegib—CYP3A4—Prednisolone—psoriatic arthritis	0.0221	0.0249	CbGbCtD
Vismodegib—ABCB1—Dexamethasone—psoriatic arthritis	0.0218	0.0245	CbGbCtD
Vismodegib—CYP3A4—Prednisone—psoriatic arthritis	0.0209	0.0235	CbGbCtD
Vismodegib—ABCB1—Methotrexate—psoriatic arthritis	0.0175	0.0197	CbGbCtD
Vismodegib—CYP3A4—Dexamethasone—psoriatic arthritis	0.013	0.0147	CbGbCtD
Vismodegib—ORM1—vertebral column—psoriatic arthritis	0.01	0.177	CbGeAlD
Vismodegib—SHH—skin of body—psoriatic arthritis	0.00623	0.11	CbGeAlD
Vismodegib—SMO—skin of body—psoriatic arthritis	0.00436	0.0768	CbGeAlD
Vismodegib—SMO—tendon—psoriatic arthritis	0.00332	0.0585	CbGeAlD
Vismodegib—Hepatic enzyme increased—Auranofin—psoriatic arthritis	0.00302	0.0554	CcSEcCtD
Vismodegib—Blood potassium decreased—Methylprednisolone—psoriatic arthritis	0.0022	0.0403	CcSEcCtD
Vismodegib—Blood potassium decreased—Prednisone—psoriatic arthritis	0.00174	0.0319	CcSEcCtD
Vismodegib—Weight decreased—Auranofin—psoriatic arthritis	0.00162	0.0297	CcSEcCtD
Vismodegib—Alopecia—Auranofin—psoriatic arthritis	0.00127	0.0232	CcSEcCtD
Vismodegib—Dysgeusia—Auranofin—psoriatic arthritis	0.00122	0.0224	CcSEcCtD
Vismodegib—Azotaemia—Methotrexate—psoriatic arthritis	0.00104	0.019	CcSEcCtD
Vismodegib—Amenorrhoea—Methylprednisolone—psoriatic arthritis	0.000951	0.0174	CcSEcCtD
Vismodegib—Dyspepsia—Auranofin—psoriatic arthritis	0.000897	0.0165	CcSEcCtD
Vismodegib—Decreased appetite—Auranofin—psoriatic arthritis	0.000886	0.0162	CcSEcCtD
Vismodegib—Constipation—Auranofin—psoriatic arthritis	0.000872	0.016	CcSEcCtD
Vismodegib—Amenorrhoea—Dexamethasone—psoriatic arthritis	0.000865	0.0159	CcSEcCtD
Vismodegib—Amenorrhoea—Betamethasone—psoriatic arthritis	0.000865	0.0159	CcSEcCtD
Vismodegib—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.000834	0.0153	CcSEcCtD
Vismodegib—Abdominal pain—Auranofin—psoriatic arthritis	0.000806	0.0148	CcSEcCtD
Vismodegib—Amenorrhoea—Prednisone—psoriatic arthritis	0.000753	0.0138	CcSEcCtD
Vismodegib—Pruritus—Auranofin—psoriatic arthritis	0.000721	0.0132	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.000698	0.0128	CcSEcCtD
Vismodegib—Diarrhoea—Auranofin—psoriatic arthritis	0.000697	0.0128	CcSEcCtD
Vismodegib—Vomiting—Auranofin—psoriatic arthritis	0.000648	0.0119	CcSEcCtD
Vismodegib—Rash—Auranofin—psoriatic arthritis	0.000643	0.0118	CcSEcCtD
Vismodegib—Dermatitis—Auranofin—psoriatic arthritis	0.000642	0.0118	CcSEcCtD
Vismodegib—Nausea—Auranofin—psoriatic arthritis	0.000605	0.0111	CcSEcCtD
Vismodegib—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.000585	0.0107	CcSEcCtD
Vismodegib—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000548	0.0101	CcSEcCtD
Vismodegib—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.000502	0.00921	CcSEcCtD
Vismodegib—Hypokalaemia—Betamethasone—psoriatic arthritis	0.000502	0.00921	CcSEcCtD
Vismodegib—Hypokalaemia—Prednisone—psoriatic arthritis	0.000437	0.00802	CcSEcCtD
Vismodegib—Weight decreased—Dexamethasone—psoriatic arthritis	0.000431	0.00791	CcSEcCtD
Vismodegib—Weight decreased—Betamethasone—psoriatic arthritis	0.000431	0.00791	CcSEcCtD
Vismodegib—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000412	0.00756	CcSEcCtD
Vismodegib—Weight decreased—Prednisone—psoriatic arthritis	0.000376	0.00689	CcSEcCtD
Vismodegib—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000365	0.0067	CcSEcCtD
Vismodegib—Breast disorder—Methotrexate—psoriatic arthritis	0.000363	0.00665	CcSEcCtD
Vismodegib—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000359	0.00657	CcSEcCtD
Vismodegib—Back pain—Triamcinolone—psoriatic arthritis	0.000354	0.00649	CcSEcCtD
Vismodegib—Alopecia—Dexamethasone—psoriatic arthritis	0.000337	0.00618	CcSEcCtD
Vismodegib—Alopecia—Betamethasone—psoriatic arthritis	0.000337	0.00618	CcSEcCtD
Vismodegib—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000327	0.00599	CcSEcCtD
Vismodegib—Myalgia—Triamcinolone—psoriatic arthritis	0.000312	0.00572	CcSEcCtD
Vismodegib—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000311	0.0057	CcSEcCtD
Vismodegib—Myalgia—Methylprednisolone—psoriatic arthritis	0.000311	0.0057	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000309	0.00566	CcSEcCtD
Vismodegib—Alopecia—Prednisone—psoriatic arthritis	0.000294	0.00539	CcSEcCtD
Vismodegib—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000292	0.00536	CcSEcCtD
Vismodegib—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00029	0.00531	CcSEcCtD
Vismodegib—Malnutrition—Prednisone—psoriatic arthritis	0.000289	0.00531	CcSEcCtD
Vismodegib—Myalgia—Betamethasone—psoriatic arthritis	0.000283	0.00519	CcSEcCtD
Vismodegib—Myalgia—Dexamethasone—psoriatic arthritis	0.000283	0.00519	CcSEcCtD
Vismodegib—Pain—Prednisolone—psoriatic arthritis	0.000278	0.0051	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000272	0.00499	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000272	0.00498	CcSEcCtD
Vismodegib—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000266	0.00488	CcSEcCtD
Vismodegib—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000266	0.00488	CcSEcCtD
Vismodegib—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000263	0.00482	CcSEcCtD
Vismodegib—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000263	0.00481	CcSEcCtD
Vismodegib—Fatigue—Triamcinolone—psoriatic arthritis	0.000258	0.00472	CcSEcCtD
Vismodegib—Fatigue—Methylprednisolone—psoriatic arthritis	0.000257	0.00471	CcSEcCtD
Vismodegib—Pain—Triamcinolone—psoriatic arthritis	0.000256	0.00469	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000247	0.00453	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000247	0.00453	CcSEcCtD
Vismodegib—Arthralgia—Prednisone—psoriatic arthritis	0.000246	0.00452	CcSEcCtD
Vismodegib—Myalgia—Prednisone—psoriatic arthritis	0.000246	0.00452	CcSEcCtD
Vismodegib—Alopecia—Methotrexate—psoriatic arthritis	0.000245	0.0045	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000245	0.00449	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000244	0.00447	CcSEcCtD
Vismodegib—Malnutrition—Methotrexate—psoriatic arthritis	0.000242	0.00443	CcSEcCtD
Vismodegib—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000239	0.00438	CcSEcCtD
Vismodegib—Dyspepsia—Betamethasone—psoriatic arthritis	0.000239	0.00438	CcSEcCtD
Vismodegib—Dysgeusia—Methotrexate—psoriatic arthritis	0.000237	0.00434	CcSEcCtD
Vismodegib—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000236	0.00432	CcSEcCtD
Vismodegib—Decreased appetite—Betamethasone—psoriatic arthritis	0.000236	0.00432	CcSEcCtD
Vismodegib—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000236	0.00432	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000234	0.00429	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000234	0.00429	CcSEcCtD
Vismodegib—Back pain—Methotrexate—psoriatic arthritis	0.000234	0.00429	CcSEcCtD
Vismodegib—Fatigue—Dexamethasone—psoriatic arthritis	0.000234	0.00429	CcSEcCtD
Vismodegib—Fatigue—Betamethasone—psoriatic arthritis	0.000234	0.00429	CcSEcCtD
Vismodegib—Pain—Betamethasone—psoriatic arthritis	0.000232	0.00425	CcSEcCtD
Vismodegib—Pain—Dexamethasone—psoriatic arthritis	0.000232	0.00425	CcSEcCtD
Vismodegib—Nervous system disorder—Prednisone—psoriatic arthritis	0.000232	0.00425	CcSEcCtD
Vismodegib—Skin disorder—Prednisone—psoriatic arthritis	0.000229	0.00421	CcSEcCtD
Vismodegib—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000222	0.00407	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000222	0.00407	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000215	0.00394	CcSEcCtD
Vismodegib—Asthenia—Triamcinolone—psoriatic arthritis	0.000214	0.00393	CcSEcCtD
Vismodegib—Abdominal pain—Betamethasone—psoriatic arthritis	0.000214	0.00393	CcSEcCtD
Vismodegib—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000214	0.00393	CcSEcCtD
Vismodegib—Asthenia—Methylprednisolone—psoriatic arthritis	0.000214	0.00392	CcSEcCtD
Vismodegib—Pruritus—Triamcinolone—psoriatic arthritis	0.000211	0.00388	CcSEcCtD
Vismodegib—Pruritus—Methylprednisolone—psoriatic arthritis	0.000211	0.00387	CcSEcCtD
Vismodegib—Dyspepsia—Prednisone—psoriatic arthritis	0.000208	0.00381	CcSEcCtD
Vismodegib—Arthralgia—Methotrexate—psoriatic arthritis	0.000206	0.00377	CcSEcCtD
Vismodegib—Myalgia—Methotrexate—psoriatic arthritis	0.000206	0.00377	CcSEcCtD
Vismodegib—Decreased appetite—Prednisone—psoriatic arthritis	0.000205	0.00376	CcSEcCtD
Vismodegib—Rash—Prednisolone—psoriatic arthritis	0.000205	0.00376	CcSEcCtD
Vismodegib—Dermatitis—Prednisolone—psoriatic arthritis	0.000205	0.00375	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000204	0.00375	CcSEcCtD
Vismodegib—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000204	0.00374	CcSEcCtD
Vismodegib—Fatigue—Prednisone—psoriatic arthritis	0.000204	0.00373	CcSEcCtD
Vismodegib—Constipation—Prednisone—psoriatic arthritis	0.000202	0.0037	CcSEcCtD
Vismodegib—Asthenia—Dexamethasone—psoriatic arthritis	0.000195	0.00357	CcSEcCtD
Vismodegib—Asthenia—Betamethasone—psoriatic arthritis	0.000195	0.00357	CcSEcCtD
Vismodegib—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000194	0.00355	CcSEcCtD
Vismodegib—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000193	0.00354	CcSEcCtD
Vismodegib—Nausea—Prednisolone—psoriatic arthritis	0.000193	0.00354	CcSEcCtD
Vismodegib—Pruritus—Betamethasone—psoriatic arthritis	0.000192	0.00352	CcSEcCtD
Vismodegib—Pruritus—Dexamethasone—psoriatic arthritis	0.000192	0.00352	CcSEcCtD
Vismodegib—Skin disorder—Methotrexate—psoriatic arthritis	0.000192	0.00351	CcSEcCtD
Vismodegib—Vomiting—Triamcinolone—psoriatic arthritis	0.00019	0.00348	CcSEcCtD
Vismodegib—Vomiting—Methylprednisolone—psoriatic arthritis	0.00019	0.00348	CcSEcCtD
Vismodegib—Rash—Triamcinolone—psoriatic arthritis	0.000188	0.00346	CcSEcCtD
Vismodegib—Dermatitis—Triamcinolone—psoriatic arthritis	0.000188	0.00345	CcSEcCtD
Vismodegib—Rash—Methylprednisolone—psoriatic arthritis	0.000188	0.00345	CcSEcCtD
Vismodegib—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000188	0.00344	CcSEcCtD
Vismodegib—Abdominal pain—Prednisone—psoriatic arthritis	0.000187	0.00342	CcSEcCtD
Vismodegib—Diarrhoea—Betamethasone—psoriatic arthritis	0.000186	0.0034	CcSEcCtD
Vismodegib—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000186	0.0034	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00018	0.0033	CcSEcCtD
Vismodegib—Nausea—Triamcinolone—psoriatic arthritis	0.000178	0.00325	CcSEcCtD
Vismodegib—Nausea—Methylprednisolone—psoriatic arthritis	0.000177	0.00325	CcSEcCtD
Vismodegib—Dyspepsia—Methotrexate—psoriatic arthritis	0.000174	0.00319	CcSEcCtD
Vismodegib—Vomiting—Betamethasone—psoriatic arthritis	0.000172	0.00316	CcSEcCtD
Vismodegib—Vomiting—Dexamethasone—psoriatic arthritis	0.000172	0.00316	CcSEcCtD
Vismodegib—Decreased appetite—Methotrexate—psoriatic arthritis	0.000172	0.00315	CcSEcCtD
Vismodegib—Rash—Betamethasone—psoriatic arthritis	0.000171	0.00313	CcSEcCtD
Vismodegib—Rash—Dexamethasone—psoriatic arthritis	0.000171	0.00313	CcSEcCtD
Vismodegib—Dermatitis—Betamethasone—psoriatic arthritis	0.000171	0.00313	CcSEcCtD
Vismodegib—Dermatitis—Dexamethasone—psoriatic arthritis	0.000171	0.00313	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00017	0.00312	CcSEcCtD
Vismodegib—Fatigue—Methotrexate—psoriatic arthritis	0.00017	0.00312	CcSEcCtD
Vismodegib—Asthenia—Prednisone—psoriatic arthritis	0.000169	0.00311	CcSEcCtD
Vismodegib—Pain—Methotrexate—psoriatic arthritis	0.000169	0.00309	CcSEcCtD
Vismodegib—Pruritus—Prednisone—psoriatic arthritis	0.000167	0.00306	CcSEcCtD
Vismodegib—Diarrhoea—Prednisone—psoriatic arthritis	0.000162	0.00296	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000161	0.00296	CcSEcCtD
Vismodegib—Nausea—Betamethasone—psoriatic arthritis	0.000161	0.00295	CcSEcCtD
Vismodegib—Nausea—Dexamethasone—psoriatic arthritis	0.000161	0.00295	CcSEcCtD
Vismodegib—Abdominal pain—Methotrexate—psoriatic arthritis	0.000156	0.00286	CcSEcCtD
Vismodegib—Vomiting—Prednisone—psoriatic arthritis	0.00015	0.00275	CcSEcCtD
Vismodegib—Rash—Prednisone—psoriatic arthritis	0.000149	0.00273	CcSEcCtD
Vismodegib—Dermatitis—Prednisone—psoriatic arthritis	0.000149	0.00273	CcSEcCtD
Vismodegib—Asthenia—Methotrexate—psoriatic arthritis	0.000142	0.0026	CcSEcCtD
Vismodegib—Nausea—Prednisone—psoriatic arthritis	0.00014	0.00257	CcSEcCtD
Vismodegib—Pruritus—Methotrexate—psoriatic arthritis	0.00014	0.00256	CcSEcCtD
Vismodegib—Diarrhoea—Methotrexate—psoriatic arthritis	0.000135	0.00248	CcSEcCtD
Vismodegib—Vomiting—Methotrexate—psoriatic arthritis	0.000125	0.0023	CcSEcCtD
Vismodegib—Rash—Methotrexate—psoriatic arthritis	0.000124	0.00228	CcSEcCtD
Vismodegib—Dermatitis—Methotrexate—psoriatic arthritis	0.000124	0.00228	CcSEcCtD
Vismodegib—Nausea—Methotrexate—psoriatic arthritis	0.000117	0.00215	CcSEcCtD
